3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Lung Neoplasms
1
Interventions
Specimen Handling
271
Magnetic Resonance Spectroscopy
228
pembrolizumab
219
Carboplatin
180
Cisplatin
146
Biopsy
143
Cyclophosphamide
137
Paclitaxel
128
Nivolumab
117
Gemcitabine
105
Bevacizumab
104
Radiotherapy
86
Dexamethasone
83
Pemetrexed
79
fludarabine
73
Fluorouracil
73
Docetaxel
73
Doxorubicin
72
atezolizumab
71
Radiation
71
Leucovorin
68
Rituximab
65
Oxaliplatin
64
venetoclax
60
Prednisone
59
durvalumab
58
Cetuximab
56
Vincristine
55
Etoposide
54
Lenalidomide
52
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Adjuvants, Pharmaceutic
×
30 days
×
Clear all
NCT06788912
2026-06-01
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2
Recruiting
60 enrolled